Table 1 Blood chemistry of subjects
From: Therapy of spinal cord injury by zinc modified gold nanoclusters via immune-suppressing strategies
Subjects | N/(n) | RBCs (1012/L) | WBCs (109/L) | Neutrophils (109/L) | Lymphocytes (109/L) | Monocytes (109/L) | Eosinophils (109/L) | Basophils (109/L) |
|---|---|---|---|---|---|---|---|---|
SCI patients | 114 | 4.0 ± 0.7* | 10.1 ± 4.6* | 8.0 ± 4.8* | 1.4 ± 0.8 | 0.52 ± 0.24* | 0.06 ± 0.09 | 0.01 ± 0.02 |
Paraplegia | 63 | 4.0 ± 0.6* | 9.6 ± 3.2* | 7.5 ± 3.3* | 1.4 ± 0.8 | 0.50 ± .23* | 0.06 ± 0.09 | 0.01 ± 0.02 |
Tetraplegia | 51 | 3.9 ± 0.8* | 10.4 ± 5.4* | 8.4 ± 5.6* | 1.5 ± 0.8 | 0.52 ± 0.26* | 0.06 ± 0.10 | 0.01 ± 0.02 |
Control | 90 | 4.5 ± 0.5 | 6.1 ± 2.8 | 3.9 ± 2.0 | 1.6 ± 0.6 | 0.45 ± 0.23 | 0.06 ± 0.10 | 0.01 ± 0.05 |